For the sixth consecutive year, CF has been recognised as one of the UK’s leading management consultancies by the Financial Times, receiving a gold rating in 2026 for our expertise in Healthcare & Life Sciences.
The FT rankings, conducted in partnership with Statista, are based on extensive surveys of clients and peers. These ratings assess the work of consultancies across 16 sectors and 15 consulting services, and we are honoured to be acknowledged for our expertise and the trust of our clients.
This year, we are proud to have been awarded for the following categories:
- Healthcare & Life Sciences – Gold
- Data Analytics & Big Data – Silver
- Innovation, Growth & New Business Models – Silver
- Digital Transformation – Bronze
Reflecting our continued growth in capabilities, we are delighted to have improved our ratings in Data Analytics & Big Data and Innovation, Growth & New Business Models – progressing from bronze to silver in both categories, alongside maintaining our gold rating in Healthcare & Life Sciences for the second year running.
Hannah Farrar, Co-Founder and CEO at CF says:
“Achieving gold in Healthcare & Life Sciences for the second consecutive year, while improving our position across other categories, demonstrates our growth trajectory and the breadth of our capabilities. Being recognised as one of only five firms to receive gold in this sector reflects our USP – we are made up of expert-led teams with sector expertise and distinctive capabilities in health data and analytics. This year we have continued to build strong partnerships with clients and have a dedicated team delivering exceptional quality across all our services.”
For further details on the full 2026 rankings and report, click here.
To learn more about our work and how we can support your organisation, get in touch today.
